嘉澤新能(601619.SH):擬合資投建260億元新能源示範基地和新能源裝備製造工業園區
格隆匯6月15日丨嘉澤新能(601619.SH)公吿,公司與雞西市人民政府、天津中車風能科技有限公司(“天津中車風能公司”)就合作開發利用雞西市風、光資源事宜進行協商,三方於2021年6月15日簽訂了《新能源產業合作框架協議書》(“《合作框架協議》”)。
公司擬與天津中車風能公司合資在雞西投資260億元建設新能源示範基地和新能源裝備製造工業園區,並於10月1日前在雞西市註冊成立100億元規模的“碳中和”新能源產業發展基金。
本次簽訂的《合作框架協議》僅為協議各方合作的意向性約定,尚存在重大不確定性,待相關具體條件達成時另行簽訂具體協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.